ArticleFrontiers in medicine2026
Multi-parametric MRI habitat radiomics with interpretable machine learning for early prediction of axillary lymph node metastasis in triple-negative breast cancer.
Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Accurate preoperative assessment of axillary lymph node metastasis (ALNM) in triple-negative breast cancer (TNBC) is essential for treatment planning. Conventional radiomics may overlook intratumoral heterogeneity (ITH) and lacks interpretability. Purpose: The study aimed to develop and validate an interpretable, multiparametric magnetic resonance imaging (mpMRI)-based habitat radiomics model for the preoperative prediction of ALNM in TNBC. Materials and methods: In this retrospective study, 125 patients with pathologically confirmed TNBC who underwent preoperative mpMRI were included. Tumors were manually segmented, and an unsupervised clustering approach was used to partition each lesion into intratumoral habitats. Radiomics features were extracted from both the whole tumor and habitat subregions. Clinical, conventional radiomics, habitat radiomics, and combined models were constructed using the eXtreme Gradient Boosting (XGBoost) algorithm. Model performance was evaluated using receiver operating characteristic (ROC) curve analysis, calibration curves, and decision curve analysis (DCA). Model discrimination was compared using DeLong's test. Shapley additive explanations (SHAP) were used for model interpretation. Results: In the training set, the clinical, conventional radiomics, habitat radiomics, and combined models achieved AUCs of 0.68, 0.76, 0.79, and 0.82, respectively. In the test set, the corresponding AUCs were 0.66, 0.70, 0.74, and 0.81. The combined model showed the best performance, while the habitat radiomics model outperformed the conventional radiomics and clinical models. In the test set, SHAP analysis identified axillary lymph node (ALN) length as the most important predictor. Conclusion: The habitat radiomics model improved predictive performance over the conventional radiomics model for preoperative ALNM assessment in TNBC, and the combined model showed the highest performance. This interpretable framework highlights the value of intratumoral heterogeneity characterization for non-invasive nodal risk stratification.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.